AstraZeneca Pty Ltd, Alma Road, North Ryde NSW 2113, Australia. ABN 54 009 682 311.
emla® is a registered trademark of AstraZeneca Pty Ltd.
References: 1. emla® Approved Product Information, March 2010 2. Data on File at AstraZeneca Pty Ltd. 3. Hamilton JG. Fam Pract 1995 Aug; 4(2): 169-175
Always read the label before using emla®. Use only as directed. See leaflet for further information.
Indications for emla®: Topical anaesthesia of the skin prior to vaccination. Active Ingredients: lignocaine 2.5% and prilocaine 2.5%.
All information displayed in this site is intended for Australian residents only and is not designed to replace the advice of your doctor or healthcare professional.